EUVIMEDEUVIMED entdecken
Open Access

Significance of Serum Lactate Dehydrogenase as a Prognostic Marker and Outcome Predictor in Patients With Breast Cancer

Geetika Malhotra, Rajesh G Gattani, Raju K Shinde, Sanjeev G Gianchandani, Krushank Nayak, Ankur Salwan

Cureus · 11.03.2024

DOI: 10.7759/cureus.55932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 11.03.2024. Verfasst von Geetika Malhotra und 5 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast carcinoma has been the most prevalent cancer in women, with research-based evidence showing a significant rise in the incidence of cancer and related morbidity and mortality in the Indian subcontinent. The predictive value of plasmatic lactate dehydrogenase (LDH) levels has been studied in breast cancer. Numerous studies have connected high LDH values to a poor prognosis, increased risk of incidence, recurrence, and associated mortality in patients with breast carcinoma. This study aimed to assess the clinical profile of breast carcinoma and determine the correlation of serum lactate dehydrogenase levels with the stage of the disease and assessment of high-risk features using histopathology and immunohistochemistry.

Methods

A total of 75 patients with carcinoma breast were enrolled for this study and classified into two groups: upfront surgery and post-adjuvant therapy. Serum LDH levels were estimated a day before the surgery (baseline) and on postoperative days 1, 7, 14, and 30. The clinical tumor, node, metastasis (cTNM) staging was correlated with pathological tumor, node, metastasis TNM (pTNM) staging and immunohistochemistry findings.

Results

The clinical characteristics of breast cancer, serum LDH levels, and stage of the disease were collected and analyzed. A significant decreasing trend was noted in LDH values post-op days, and statistically significant higher LDH values were noted in the triple-negative group, positive lymph nodes, and positive lymphovascular invasion patients.

Conclusion

Regularly elevated levels or an unanticipated rise in serum LDH might indicate poor outcomes. Hence, this non-specific enzyme marker can be suggested to be used routinely to assess disease outcomes.

Schlagwörter

Stichwörter der Autor:innen

ca breast prognostic markerscarcinoma breastlactate dehydrogenaselymphovascular invasiontnm stage

Autor:innen und Institutionen

  • General Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.
  • Minimal Access and Robotic Surgery, Anglia Ruskin University, Chelmsford, GBR.
  • Orthopaedic Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.

Zitieren

APA

Malhotra, G., Gattani, R. G., Shinde, R. K., Gianchandani, S. G., Nayak, K., & Salwan, A. (2024). Significance of Serum Lactate Dehydrogenase as a Prognostic Marker and Outcome Predictor in Patients With Breast Cancer. Cureus. https://doi.org/10.7759/cureus.55932

Vancouver

Malhotra G, Gattani RG, Shinde RK, Gianchandani SG, Nayak K, Salwan A. Significance of Serum Lactate Dehydrogenase as a Prognostic Marker and Outcome Predictor in Patients With Breast Cancer. Cureus. 2024. doi:10.7759/cureus.55932

BibTeX
@article{Malhotra2024,
  author = {Malhotra, Geetika and Gattani, Rajesh G and Shinde, Raju K and Gianchandani, Sanjeev G and Nayak, Krushank and Salwan, Ankur},
  title = {Significance of Serum Lactate Dehydrogenase as a Prognostic Marker and Outcome Predictor in Patients With Breast Cancer},
  journal = {Cureus},
  year = {2024},
  doi = {10.7759/cureus.55932}
}
Kostenlos starten →